ArticleFrontiers in oncology2022

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes.

Maciej J Pelak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.